Diagnostic imaging system developer Digirad has received U.S. Food and Drug Administration 510(k) marketing clearance for its new nSPEED reconstruction software.

The product, for use with SPECT systems, is used to achieve reduced imaging time and improved image quality with less radiation exposure for patients, according to the Poway, Calif.-based company.

The firm said that with nSPEED its Digirad Cardius solid-state dedicated cardiac systems can now perform cardiac SPECT imaging procedures in as little as three minutes or with one-half the required pharmaceutical dosages.